Differences in Skilled Nursing Facility Characteristics and Quality Ratings by Long-Term Care Pharmacy Provider

Author:

Zullo Andrew R.ORCID,Riester Melissa R.,Goldberg Elizabeth M.,Cupp Meghan A.,Berry Sarah D.,Beaudoin Francesca L.

Abstract

ABSTRACTObjectivesLimited data exist on the U.S. long-term care (LTC) pharmacy market and how skilled nursing facilities (SNFs) may differ by LTC pharmacy provider. We estimated the market shares of two major LTC pharmacies (Omnicare and PharMerica) and assessed if SNF characteristics differ by pharmacy.DesignCross-sectional.Setting and ParticipantsSeventy-five Rhode Island (RI) SNFs that provided post-acute care (PAC) services in 2019.MethodsSNF location, structure, staffing measures, and quality ratings were ascertained from publicly available data sources. The LTC pharmacy used by each SNF was compiled by case managers at a RI health system.ResultsAmong 75 SNFs, 32 (43%) were served by Omnicare and 36 (48%) by PharMerica. LASSO logistic regression and random forest models identified 5 key predictors of SNFs selecting PharMerica over Omnicare: number of skilled beds, total number of beds, nursing hours per resident per day, five-star health inspection rating, and average number of residents per day. In a multivariable regression model including 4 predictors (total number of beds excluded due to collinearity), SNFs had a 6% higher prevalence of using Omnicare over PharMerica for every additional 10 skilled beds (Prevalence Ratio 1.06, 95% CI 1.02-1.10).Conclusions and ImplicationsOmnicare and PharMerica comprised over 90% of the SNF PAC market in RI, with Omnicare covering larger facilities. Understanding if these companies serve a similar proportion of SNFs in other U.S. states is necessary to advance future research initiatives and examine how collaborations between SNFs and LTC pharmacy chains may improve medication management in SNFs.Brief SummaryTwo pharmacies may comprise over 90% of the skilled nursing facility post-acute care market. This market concentration may represent a prime opportunity to efficiently improve medication management.

Publisher

Cold Spring Harbor Laboratory

Reference20 articles.

1. Oliver K. Active immunity: The aging population will strengthen industry revenue. IBISWorld Industry Report OD5707 Institutional Pharmacies in the US; 2018.

2. Avalere. Long-Term Care Pharmacy: the Evolving Marketplace and Emerging Policy Issues. 2015.

3. In the Matter of Omnicare, Inc. a corporation, United States of America Before the Federal Trade Commission, (2012).

4. Dwyer L , Han B , Woodwell D , Ea R. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother. 2010;

5. Comparative safety of dipeptidyl peptidase‐4 inhibitors and sulfonylureas among frail older adults

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3